Hefei Huana Biomedical Technology Co.,Ltd company profile
Established in 2017, Hefei Huana Biomedical Technology Co., Ltd is a wholly-owned subsidiary of Anhui Okeanos Technology Co., Ltd.The company has a number of high-tech talents from Peking University, Tsinghua University and the Chinese Academy of Sciences, who are committed to the R & D and production of molecular diagnostic reagents, drug intermediate technology and API. Our products cover IVD reagents, fluorescent dyes, ingredients for DNA& RNA synthesis,high-throughput sequencing, life science research, small nucleic acid drugs and other fields. We own our nucleic acid production base, which is designed and builtin strict accordance with international standards. The main body finished construction work of the infrastructure in 2020, the equipment installation in 2021 and fully operation in early 2022. The No.1 workshop has an annual output of 8000L dNTP, 20000L rNTP (including Pseudouridine and N-methyl-Pseudouridine), 20Tons of phosphoramidites and 20Tons of other modified nucleoside items.
With the long-term accumulation in the field of nucleic acid chemistry and dye chemistry, and relying on the technical and resource advantages of our parent company Anhui Okeanas Technology Co. As a domestic technology support part, it has been included in the implementation plan of biotechnology-related tasks of the "Key Core Technology Tackling Special Project" of the Ministry of Science and Technology, and has become an important implementation unit of the key projects of the "National 13th Five-Year Plan". At present, the company has reached a good cooperation relationship with domestic and foreign famous brands in the field of nucleic acid diagnosis and treatment, and continues to reserve the technology base to advance to the high-end of the value chain.
Hefei Huana Bio-pharmaceutical Technology Co., Ltd. is a scientific and innovative industrial platform integrating R&D, production and sales of biochemical and pharmaceutical intermediates. We are dedicated to the development and industrialization of core raw materials such as gene therapy reagents, small nucleic acid drugs, synthetic biology, fluorescent and chemiluminescent dyes.
The company is headquartered in Hefei Circular Economy Demonstration Park, covering an area of about 100 acres with a total construction area of 60,000 square meters, which is a modern production base designed and built according to GMP standards. Since its establishment, the company has been recognized as a national high-tech enterprise, a regulated enterprise and a high-growth seed enterprise, and is one of the important supporting enterprises of the supporting Hefei Large Gene Center. in December 2021, the company successfully moved to a new production base, opening a new chapter of rapid development!
Relying on the high-tech biological resources of Okeanas and strong technical support from partners such as Peking University, Fudan University and University of Science and Technology of China, the company is a supporting enterprise of the supporting Hefei Large Gene Center and a gene big health industry chain enterprise in which UW-Gene participates and invests. It is committed to the development and production services of molecular diagnostic reagents, drug intermediate technologies and APIs, and strives to become an advanced and modern GMP production base in China after the completion of the project.